MedPath

UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare the Intrauterine Pathology Detection Rate Between Standard of Care Hydrosonography, and a New Visual Saline Infusion Device Providing Direct Visualization of the Uterus.

Not Applicable
Recruiting
Conditions
Hysteroscopy Technique
Fertility Issues
Gynecology
Visualization
Hysteroscopy
Uterus Abnormal
Infertility Female
Interventions
Device: Visual Saline Infusion
Device: Hydrosonography
Registration Number
NCT06394752
Lead Sponsor
Center for Reproductive Health & Gynecology
Brief Summary

This is a prospective, single center, multiple arm cohort study intended to compare the diagnostic accuracy of a Visual Saline Infusion Device (VSI) device, vs standard of care Hydrosonography in reproductive aged women to identify pathology in the uterus.

Detailed Description

This is a prospective, single center, multiple arm cohort study intended to compare the diagnostic accuracy of a Visual Saline Infusion Device (VSI) device, vs standard of care Hydrosonography in reproductive aged women to identify pathology in the uterus.

Patients who are enrolled in the study will have a 1) Hydrosonography, and 2) Visual Saline Infusion procedure performed.

The Visual Saline Infusion Device is a 2.7mm, steerable tip catheter with a camera and illumination at the distal end. The device is intended to evaluate the intrauterine space in an office based, outpatient setting using minimal volume of fluid (3-5cc's).

This study will recruit up to 100 women from a fertility center in Los Angeles.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  1. Patients requiring a uterine cavity evaluation
  2. Premenopausal women between ages of 18-45
Exclusion Criteria
  1. Positive test or history of any of the following conditions:

1a. Chlamydial pelvic infection

1b. Gonorrheal pelvic infection. 2. Positive Pregnancy Test 3. IUD currently in place

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Visual Saline InfusionVisual Saline InfusionVisual Saline Infusion is intended to perform direct visual evaluation of the intrauterine space using a 2.7mm, steerable tip catheter with a camera.
HydrosonographyHydrosonographyHydrosonography is the standard of care for intrauterine evaluation. It is performed by inserting a slim 2 mm catheter into the uterine cavity and infusing saline solution to expand the uterus, and using abdominal ultrasound to detect intrauterine pathology.
Primary Outcome Measures
NameTimeMethod
Intrauterine pathology detection rate with Visual Saline InfusionProcedure of approximately 2-5 minute duration

The assessment will involve the examination of the intrauterine cavity for the presence of known pathologies, including polyps, fibroids, adhesions, scar tissue, thickened endometrium, among others. The detection rate will be calculated as the ratio of the number of cases where abnormal pathologies are identified to the total number of cases examined.

Intrauterine pathology detection rate with HydrosonographyProcedure of 2-5 minute duration

The assessment will involve the examination of the intrauterine cavity for the presence of pathologies, including polyps, fibroids, adhesions, scar tissue, thickened endometrium, among others. The detection rate will be calculated as the ratio of the number of cases where abnormal pathologies are identified to the total number of cases examined.

Secondary Outcome Measures
NameTimeMethod
Visual detection quality score (1-10)Captured during procedure

The visual detection quality score will be assessed using a normalized scale ranging from 1 (indicating poor or no visualization) to 10 (indicating excellent visualization), with scores assigned based on the clarity and detail of the intrauterine images obtained during the examination.

Pain during procedureCollected on day of procedure

The research team will interview the Subject and record the level of pain experienced based on the Wong Baker pain scale

Fluid used during distentionCaptured during procedure

The volume of fluid used for distention of the uterus will be documented.

Adverse events rateDay of procedure and 24-48 hours post to procedure

Anticipated and unanticipated adverse events will be documented

Trial Locations

Locations (2)

Center for Reproductive Health & Gynecology

🇺🇸

Beverly Hills, California, United States

Punta Mita Fertility Center

🇲🇽

Corral Del Risco, Nayarit, Mexico

© Copyright 2025. All Rights Reserved by MedPath